Mirum Pharmaceuticals, Inc. financial data

Symbol
MIRM on Nasdaq
Location
Foster City, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305% % -8.7%
Quick Ratio 15% % -21%
Debt-to-equity 178% % -5.2%
Return On Equity -8.5% % 78%
Return On Assets -3.1% % 77%
Operating Margin -4.2% % 84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60,341,617 shares 22%
Common Stock, Shares, Outstanding 51,896,391 shares 7.4%
Entity Public Float $2,300,000,000 USD 53%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,198,304 shares 5.6%
Weighted Average Number of Shares Outstanding, Diluted 50,198,304 shares 5.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $521,312,000 USD 55%
Operating Income (Loss) $22,136,000 USD 75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $21,427,000 USD 75%
Income Tax Expense (Benefit) $1,936,000 USD 88%
Net Income (Loss) Attributable to Parent $23,363,000 USD 73%
Earnings Per Share, Basic -0.47 USD/shares 75%
Earnings Per Share, Diluted -0.47 USD/shares 75%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $296,683,000 USD 33%
Accounts Receivable, after Allowance for Credit Loss, Current $123,330,000 USD 58%
Inventory, Net $24,887,000 USD 11%
Assets, Current $549,684,000 USD 40%
Property, Plant and Equipment, Net $1,862,000 USD 63%
Operating Lease, Right-of-Use Asset $8,741,000 USD 0.76%
Intangible Assets, Net (Excluding Goodwill) $260,921,000 USD 4.4%
Other Assets, Noncurrent $12,018,000 USD 123%
Assets $842,813,000 USD 26%
Accounts Payable, Current $9,614,000 USD -34%
Employee-related Liabilities, Current $47,276,000 USD 47%
Accrued Liabilities, Current $196,185,000 USD 75%
Liabilities, Current $205,799,000 USD 63%
Operating Lease, Liability, Noncurrent $7,516,000 USD -5.7%
Other Liabilities, Noncurrent $5,011,000 USD 100%
Liabilities $528,123,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $351,000 USD
Retained Earnings (Accumulated Deficit) $667,544,000 USD -3.6%
Stockholders' Equity Attributable to Parent $314,690,000 USD 39%
Liabilities and Equity $842,813,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,961,000 USD -113%
Net Cash Provided by (Used in) Financing Activities $6,359,000 USD 428%
Net Cash Provided by (Used in) Investing Activities $16,134,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 51,896,391 shares 7.4%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,681,000 USD -165%
Deferred Tax Assets, Valuation Allowance $181,822,000 USD 8.6%
Deferred Tax Assets, Gross $183,447,000 USD 8.3%
Operating Lease, Liability $9,655,000 USD -0.27%
Payments to Acquire Property, Plant, and Equipment $41,000 USD 215%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $22,639,000 USD 75%
Lessee, Operating Lease, Liability, to be Paid $11,122,000 USD -2.9%
Operating Lease, Liability, Current $2,139,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,856,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,771,000 USD 17%
Operating Lease, Weighted Average Discount Rate, Percent 0.074 pure -1.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,467,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,922,000 USD 17%
Deferred Tax Assets, Operating Loss Carryforwards $45,302,000 USD 18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $17,124,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,201,000 USD -12%
Operating Lease, Payments $583,000 USD 102%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $23,900,000 USD 3.5%
Depreciation, Depletion and Amortization $6,052,000 USD 6.8%
Share-based Payment Arrangement, Expense $71,424,000 USD 47%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%